Study to Evaluate the Effect of Adding five different compounds to Fluticasone Propionate 100 mcg Inhalation Powder Twice Daily in Uncontrolled Asthmatic Subjects ≥12 Years of Age. - Trial 2010-019466-81

Name: Clinical Trial 2010-019466-81
Creator: GlaxoSmithKline Research & Development
Keywords: Asthma, clinical trial

Access comprehensive clinical trial information for 2010-019466-81 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development and is currently status unknown. The study focuses on Asthma.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2010-019466-81

Trial Details

EU Clinical Trials Register • 2010-019466-81

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Study to Evaluate the Effect of Adding five different compounds to Fluticasone Propionate 100 mcg Inhalation Powder Twice Daily in Uncontrolled Asthmatic Subjects ≥12 Years of Age.

Study Focus

Disease/Condition

Asthma

Sponsor & Location

Primary Sponsor

GlaxoSmithKline Research & Development

Funder

GlaxoSmithKline Research & Development Ltd.

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

The primary efficacy endpoint was trough (AM pre-dose and pre-rescue bronchodilator) forced expiratory volume in 1 second (FEV1) at the end of the 6-week treatment period.

ICD-10 Classifications

Asthma

Asthma, unspecified

Nonallergic asthma

Mixed asthma

Predominantly allergic asthma

Data Source

Registry

EU Clinical Trials Register

Trial ID

2010-019466-81

Type

Non-Device Trial